{"transactions":[{"id":3255879,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151473,"kind":"person","name":"Knifsend Robin","position":1,"cik":"0001777516","reported_name":"Knifsend Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-21T17:34:43.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2020 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":34000,"derivative":{"exercise_price":7.13,"expiration_date":"2030-02-13","underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001567619-20-004554","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761920004554/doc1.xml","form_type":"4"}},{"id":3501772,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":151473,"kind":"person","name":"Knifsend Robin","position":1,"cik":"0001777516","reported_name":"Knifsend Robin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Principal Accounting Officer"}}],"security":"Common Stock","published_at":"2019-06-04T20:06:36.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":1812,"price":8.211,"value":14878.332,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"1,812 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":2791,"source":{"system":"sec-edgar","filing":"0001567619-19-012669","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761919012669/doc1.xml","form_type":"4"}}]}